This brief summarizes public reporting and official announcements. Research findings may be preliminary. Talk to a qualified clinician before making health decisions.
This event has left the current brief. The summary below describes the stored record; open the original sources for current conditions.
HHS is temporarily allowing compounding pharmacies to make six peptides that are not FDA-approved. The policy does not establish that the products are safe or effective, and the supplied reports say officials are considering further action.
HOW THIS BRIEF WAS MADE 16 outlets: 11 national · 2 international · 2 specialist · 1 trade press. Automated sourcing and summaries by the BLUF engine. Corrections
The policy may expand access to these products through prescriptions, affecting patients, prescribers and compounding pharmacies. Because the peptides have not been approved by the FDA, the change is not evidence that they have been shown to be safe or effective.